Excerpt from the last report -
“Our primary focus over the past three months or so has been to secure one or more new pipeline assets that we can bring into the company,” commented Percheron CEO, Dr James Garner. “We have a number of promising leads under discussion, and we are highly optimistic that we will be in a position to re-launch the company mid-year with a new story and as a compelling new opportunity for investors. In the meantime, our discussions and negotiations continue, and we will endeavour to provide as much information as we can to investors as matters progress.”
Well, mid-year is here and we are still in the dark, so J.G. had better come up with something soon or investors will start to get restless and maybe another challenge could be on the cards?? - Let's have some newsflow to calm the nerves!
GLTAH
.
- Forums
- ASX - By Stock
- PER
- Ann: Quarterly Activities Report and Appendix 4C
PER
percheron therapeutics limited
Add to My Watchlist
10.0%
!
0.9¢

Ann: Quarterly Activities Report and Appendix 4C, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $9.786M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $94.66K | 10.09M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 661860 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1588275 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 661860 | 0.009 |
5 | 2998000 | 0.008 |
2 | 1142857 | 0.007 |
2 | 1999997 | 0.006 |
2 | 3200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1588275 | 6 |
0.011 | 2500000 | 6 |
0.012 | 2758324 | 6 |
0.013 | 691461 | 3 |
0.014 | 1572000 | 3 |
Last trade - 15.52pm 27/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online